George S. Barrett
Independent DirectorMr. George S. Barrett is Founder of The Overtone Group, L.L.C. He serves as Senior Advisor at Invidia Capital Management LP and as an Independent Director of Target Corporation since November 5, 2018. He also serves on several boards, including as a Member of the Advisory Board at Attainment Holdco, LLC; a Member of the Advisory Board of InStride; an Independent Director of Columbus Downtown Development Corporation; Vice Chairman at The Conference Board, Inc.; a Board Member for the Generic Pharmaceutical Industry Association (GPhA); a Director of The American Foundation for Pharmaceutical Education (APFE); a Director of The University of Maryland School of Pharmacy; a Member of the Business Advisory Board of Cera Products, Inc.; an Independent Director of Nationwide Children's Hospital, Inc.; and a Director of the Rock and Roll Hall of Fame. His affiliations include serving on the President's Leadership Council of Brown University, the National Academy of Medicine’s President’s Advisory Council on Healthy Longevity, the board of Brown’s Watson Institute for International and Public Affairs and as trustee of the Healthcare Leadership Council. He co-chairs the National Academy of Medicine Action Collaborative on Decarbonizing the U.S. Health Sector. In academia, he is an Adjunct Assistant Professor at Columbia University Mailman School of Public Health and a visiting professor of practice and senior fellow at New York University’s Stern School of Business. He is also a trustee emeritus of Brown University. He served as a Director at National Resilience, LLC until 2026. He served as a Director at Digital Diagnostics Inc. from January 2021 to 2025. He was an Independent Director of Montes Archimedes Acquisition Corp. from October 2020 to September 30, 2021. He served as Director at Olive AI, Inc. until 2021. He was a Director of the Federal Reserve Bank of Cleveland from February 2018 to December 2018. He was employed at Cardinal Health, Inc. from January 2008 to November 7, 2018, where he served in several roles. He served as Director from August 2009 to November 7, 2018, as Executive Chairman from January 1, 2018 to November 2018, as Chairman and Chief Executive Officer from 2009 to January 1, 2018 and as Vice Chairman and Chief Executive Officer of Healthcare Supply Chain Services from January 2008 to September 2009. He also served as Chairman of Cardinal Health Inc and Chief Executive Officer of Cardinal Health Inc of Cardinal Health 414, LLC. He served as EVP of Global Pharmaceutical Markets, CEO & President of TevaNorth America at Teva Pharmaceutical Industries Limited, where he was employed from January 2005 to January 2008. At Teva Pharmaceutical Industries Ltd., he also served as Executive Vice President of Global Pharmaceutical Markets from March 2007 to January 2008, as President and Chief Executive Officer for North America from January 2005 to January 2008 and as Group Vice President of North America since January 2005. He also served as CEO & President of North America of Teva Pharmaceutical Industries Ltd of Teva Pharmaceuticals USA, Inc. At Teva Pharmaceutical Finance LLC, which he joined in March 1999, he served as Chief Executive Officer of Teva USA and President of Teva USA until November 30, 2004. He served as President and Director of IVAX LLC, which he joined on January 26, 2006. He served as an Independent Director of Eaton Corporation plc from April 27, 2011 to April 22, 2015. He served as the Chairman for the Generic Pharmaceutical Industry Association (GPhA). Prior to joining Teva in 1999, he served as the President and Chief Executive Officer of Diad Research. He served as President of Alpharma' U.S. pharmaceutical group from 1994 to 1997 and as President of Barre National from 1991 to 1994. From 1981 to 1991, he served in various positions with NMC Laboratories, serving as President from 1988. Mr. Barrett has experience in areas such as manufacturing, regulatory compliance, finance, strategic planning and supply chain management and was responsible for Teva's Global Market Management, including strategies for positioning Teva in key markets. He was recognized multiple times by Institutional Investor as a Top CEO on the All-America Executive Team, as a Top CEO in the annual Glassdoor Employees’ Choice Awards and is a recipient of the Ellis Island Medal of Honor and Peter G. Peterson Business Statesmanship Award. Mr. Barrett earned his B.A. in History & Music from Brown University in 1977 and his M.B.A. from New York University in 1988. He also holds an Honorary Doctor of Humane Letters degree from Long Island University’s Arnold & Marie Schwartz College of Pharmacy and Health Sciences and an Honorary Doctorate of Fine Arts from the Columbus College of Art and Design.
Positions
- Company NameTarget CorporationStock CodeTGTPositionIndependent Director
